Table 3.
Performance by indicators and changes over time (% goal achieved).
| Indicator/Group | Baseline | 3 Months | Δ (%1) | 6 Months | Δ (%2) |
|---|---|---|---|---|---|
| Hemoglobin A1C, mean (SD/%) | |||||
| Prediabetes (n = 50) | 6.2 (0.2) | 5.8 (0.5) | −0.4c (26.0%) | 5.6 (0.4) | −0.5c (56.0%) |
| Moderate (I; n = 114) | 7.0 (0.5) | 6.5 (0.6) | −0.5c (22.8% | 6.2 (0.6) | −0.8c (66.7%) |
| Severe (II; n = 51) | 9.5 (1.3) | 7.7 (1.2) | −1.8c (49.0%) | 7.2 (1.1) | −2.3c (47.1%) |
| Total (I & II) (n = 165) | 7.8 (1.4) | 6.9 (1.0) | −0.9c (37.6%3) | 6.5 (0.9) | −1.3c (51.5%3) |
a
p < 0.05
b
p < 0.01
c
p < 0.001 using paired t-test (two-tailed) compared to baseline.
1
Proportion of objective achieved at 3 months (A1C reduction <−0.5% for prediabetes, <−1.0% for moderate diabetes group and <−1.5% for severe diabetes group).
2
Proportion of objective achieved at 6 months (A1C <5.7% for prediabetes group, <6.5% for moderate diabetes group and <7.0% for severe diabetes group).
3
Proportion of A1C reduction <−1.0% at 3 months and A1C < 6.5% at 6 months.